Caxton Associates (New York)’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q1
Sell
-1,156,519
Closed -$152M 552
2022
Q4
$152M Buy
+1,156,519
New +$152M 10.13% 2